HSP90AA1 and breast carcinoma: In addition, in breast cancer with high levels of HER2 expression and amplification of AKT, Hsp90 inhibitor 17-AAG sensitized breast cancer cells to Taxol by causing the degradation of HER2 and the inactivation of Akt both in vitro and in vivo [32].